Retrospective Study on Clinical Performance and Safety Profile of Agile Nail — Agile

Fractures, Bone Clinical Trial

Official title:
Multicenter Retrospective Observational Study to Assess the Clinical Performance and Safety Profile of Agile Nail in Paediatric Patients Who Have Suffered Femoral Shaft and Subtrochanteric Fractures or Have Performed Prophylactic Nailing of Impending Pathologic Fractures or Have Undergone Fixation of Femurs That Have Been Surgically Prepared for Deformity Correction: Agile Study

Status Not yet recruiting

Clinical Trial Summary

This study aims to retrospectively collect data from routine clinical practice in order to evaluate the safety profile of the Agile intramedullary nail, used in pediatric patients according to the manufacturer Instructions For Use (IFU) in the time frame from the time of surgery until the last follow-up visit available at the hospitals.

Clinical Trial Description

The study will be conducted in two investigational sites, one in France and one in United Kingdom, both experienced in the treatment of pediatric patients with femoral shaft and subtrochanteric fractures and deformity correction procedures or have performed prophylactic nailing of impending pathologic fractures, where the usage of AGILE NAIL (known as AGILE) was part of the normal clinical practice. Investigator of both study sites will provide data for a maximum of 45 patients meeting inclusion and exclusion criteria (Considering a drop-out or a non-evaluable rate of 10% of the procedures) that will contribute for approximately 45 procedures in which AGILE was used. No diagnostic or therapeutic intervention outside of routine clinical practice will be applied. The study has been designed to analyze medical records of patients where study data was collected as part of their routine clinical practice. Therefore, patients will be retrospectively enrolled in the study. Patients who have undergone AGILE implantation from 04/2018 to 12/2022 are considered for the study. The observation period of study subjects will comprise from surgery until the last follow up visit available. Medical records of the participating sites are expected to contain all the required information. In United Kingdom, no study visit will be required but according to local legislation, it will be essential that before collecting any information from medical records, participants or their guardians are asked for specific informed consent to be signed by them before any collection of patient information takes place. However, in France, due to the use of primary data and the foreseen exemption of the informed consent (IC) form (see Section 14.2 Informed Consent), no study visit will be required. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06412939
Study type	Observational
Source	Orthofix s.r.l.
Contact	Edo Knijff
Phone	+390456719000
Email	EdoKnijff@orthofix.it
Status	Not yet recruiting
Phase
Start date	June 2024
Completion date	June 2025

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05555459` - Performance and Safety Evaluation of Inion CompressOn Screw in Foot and Ankle Surgeries. PMCF Investigation	N/A
Completed	`NCT03147222` - Function Focused Care: Fracture Care at Home	N/A
Completed	`NCT03506958` - Patient Satisfaction in Treatment of Non-complex Fractures and Dislocations in Hospitals vs General Practitioners
Completed	`NCT04426981` - Behavioral Activation in Orthopaedic Trauma Patients: A Pilot Study	N/A
Recruiting	`NCT04389749` - Continuous Passive Motion Following Fixation of Pelvic and Knee Fractures	N/A
Recruiting	`NCT05068180` - Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients	Phase 4
Recruiting	`NCT05594199` - Feasibility of a Virtual Smoking Cessation Program	N/A
Completed	`NCT04514601` - A Quality Improvement Project to Assess and Refine the Handover Process at Morning Trauma Meetings
Completed	`NCT02272972` - Performance Improvement Program on Imaging II
Completed	`NCT05138640` - Bone Strength and Physical Activity in Patients With a Recent Clinical Fracture
Completed	`NCT04215315` - Fracture In Preterm Infants Study (FIPIN Study)
Completed	`NCT03219125` - Bone Marrow Adiposity and Fragility Fractures in Postmenopausal Women
Terminated	`NCT05655130` - Distal Radius Steroid	Phase 1
Completed	`NCT04151732` - Factors Associated With Future Fractures in Middle-aged Men and Women
Completed	`NCT02714257` - Working to Increase Stability Through Exercise	N/A
Completed	`NCT02428244` - Let's STOP Now Trial: Smoking in Trauma Orthopaedic Patients	N/A
Recruiting	`NCT04501510` - Ultrasonography in Fracture Management
Completed	`NCT03852095` - Single Time Management Diseases in Pediatric Traumatology
Completed	`NCT04440631` - Gut Microbiome of Patients Undergoing Antibiotic Therapy for Orthopedic Device-related Infection
Completed	`NCT03370900` - Learning Retention in Radiograph Interpretation	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.